MARSHALL WACE, LLP - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 120 filers reported holding CUREVAC N V in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CUREVAC N V
ValueSharesWeighting
Q3 2023$798,366
-5.5%
116,891
+44.1%
0.00%0.0%
Q2 2023$845,239
+42.4%
81,117
-4.7%
0.00%
+100.0%
Q1 2023$593,545
-83.5%
85,161
-85.7%
0.00%
-87.5%
Q4 2022$3,589,429
+36.5%
595,262
+78.3%
0.01%
+33.3%
Q3 2022$2,629,000
-41.9%
333,819
+0.5%
0.01%
-33.3%
Q2 2022$4,522,000
+34.3%
332,061
+93.3%
0.01%
+50.0%
Q1 2022$3,368,000
-6.6%
171,782
+335.8%
0.01%
-64.7%
Q1 2021$3,605,000
+528.0%
39,415
+219.5%
0.02%
+325.0%
Q3 2020$574,00012,3350.00%
Other shareholders
CUREVAC N V shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,709,781$23,300,00017.91%
Pinz Capital Management, LP 40,200$547,0000.38%
Parametrica Management Ltd 13,513$184,0000.20%
MQS Management LLC 16,176$220,0000.15%
Quantamental Technologies LLC 11,552$157,0000.07%
Ergoteles LLC 98,100$1,335,0000.04%
Virtus ETF Advisers LLC 7,676$104,0000.04%
Green Alpha Advisors, LLC 12,247$167,0000.04%
ETF MANAGERS GROUP, LLC 53,789$746,0000.02%
Quantbot Technologies LP 14,800$201,0000.02%
View complete list of CUREVAC N V shareholders